Early phase group (n = 20) | Later phase group (n = 42) | P value | |
---|---|---|---|
Age(mean ± SD) | 54.35 ± 10.48 | 53.98 ± 12.02 | 0.906 |
Gender (%) | 0.544 | ||
Female | 11(55%) | 24(57.1%) | |
Male | 9(45%) | 18(42.9%) | |
Number of spinal metastases (%) | 0.677 | ||
multiple | 20(100%) | 41(97.6%) | |
single | 0 | 1(2.4%) | |
Surgical site (%) | 0.294 | ||
Thoracic | 15(75%) | 27(64.3%) | |
lumbar | 5(25%) | 15(35.7%) | |
Coagulation dysfunction | |||
Normal | 18(90%) | 42(100%) | 0.189 |
Abnormal | 2(10%) | 0 | |
Diabetes | |||
Normal | 20(100%) | 39(92.9%) | 0.554 |
Abnormal | 0 | 3(7.1%) |